In medicine, a guideline published by a specialty association is more than a “suggestion.” If a doctor varies from that guideline, he or she is presumed guilty of varying from the standard of care. And had better find a defense lawyer, because there’s a good chance she’ll be sued for malpractice or, in the case … Continue reading
>In medicine, a guideline published by a specialty association is more than a “suggestion.” If a doctor varies from that guideline, he or she is presumed guilty of varying from the standard of care. And had better find a defense lawyer, because there’s a good chance she’ll be sued for malpractice or, in the case … Continue reading
This pro-abortion rant from the San Antonio Current is really reaching: Frank Corte is a pro-life legislator who wants to control Texas’s women and health professionals. With HB 21, he wants to deny women the ability to review abortion warnings privately on video, and instead force them to hear it directly from the doctor; with … Continue reading
>This pro-abortion rant from the San Antonio Current is really reaching: Frank Corte is a pro-life legislator who wants to control Texas’s women and health professionals. With HB 21, he wants to deny women the ability to review abortion warnings privately on video, and instead force them to hear it directly from the doctor; with … Continue reading
Ignoring the ignoble vote in the House of Representatives today, and without a prior posting about the recent report concerning amniotic and placental stem cells, Art Caplan has posted a little political rant about the politics of stem cells. Caplan is a pseudoeditor over at blog.bioethics.net has once again claimed that someone else is telling … Continue reading
Since Mr. Reed has urged us to follow the money trail, and after my talk with the banker last week, I was pleased to see that others are looking at ethical stem cells as an investment. The business journal, Bloomberg, reported on several companies that are involved in ethical stem cell research. Evidently, these companies … Continue reading
>Since Mr. Reed has urged us to follow the money trail, and after my talk with the banker last week, I was pleased to see that others are looking at ethical stem cells as an investment. The business journal, Bloomberg, reported on several companies that are involved in ethical stem cell research. Evidently, these companies … Continue reading
I edited yesterday’s first article on the Amniotic/Placental stem cells reported in Nature Biotechnology. I had mispelled “De Coppi” and had mistakenly reported that Krabbe’s disease was the focus of the experiments with fetal tissue implants in young Daniel Kerner. In fact, Daniel is being treated for Batten’s Disease.
>I edited yesterday’s first article on the Amniotic/Placental stem cells reported in Nature Biotechnology. I had mispelled “De Coppi” and had mistakenly reported that Krabbe’s disease was the focus of the experiments with fetal tissue implants in young Daniel Kerner. In fact, Daniel is being treated for Batten’s Disease.
Don C. Reed, a rabid supporter of embryonic stem cell research – and, it seems, only stem cell research – has written an editorial, “Coincidence or Con-Job?” He flatly states that he believes that we are witnessing an act of “weapons of mass deception” in the timing of the release of the newest issue of … Continue reading